drugset / Trial / NCT04401917

Evaluation of Neuroinflammation FNOS PET/CT in HIV (+) and (-) Subjects With OUD and Healthy Controls

NCT04401917 ↗

Phase 0 Active not recruiting 26 enrolled University of Pennsylvania
Non-randomizedParallel-groupSingle-blindOther

Summary

The purpose of this research is to measure the extent of inflammation in the brain between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body. This study will see how the tracer is taken up in the brain using an imaging scan called Positron Emission Tomography / Computed Tomography (PET/CT). Participants will undergo approximately 60 minutes of dynamic scanning of the brain starting at approximately the time of injection of \[18F\]NOS. Participants are required to have a brain MRI performed within 1 year prior to study enrollment, or if the subject has not had a brain MRI that is deemed acceptable for use for this study they will be asked to undergo a research brain MRI after they have consented for this study.

Timeline

Start
2020-12-07
Primary completion
2026-12-07
Completion
2026-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]NOS Diagnostic / imaging agent 240.5 mbq Other